Value of Immunomodulator drug(probiotics) in lung function of Bronchial Asthma subjects
Not Applicable
- Conditions
- Health Condition 1: J454- Moderate persistent asthma
- Registration Number
- CTRI/2021/03/032105
- Lead Sponsor
- Boopathi S
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All adult stable asthma with or without atopy and allergic rhinitis
Both genders
Exclusion Criteria
Acute Respiratory infection including Tuberculosis
Exacerbation
Subjects contraindicated and unable to perform spirometry
Underlying respiratory disorders
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the role of add on probiotics on impact of lung function by spirometry and bronchial asthma controlTimepoint: Baseline,4 weeks,8 weeks and 12 weeks
- Secondary Outcome Measures
Name Time Method To study the impact of probiotics supplementation in risk of asthma exacerbation allergic rhinitis and its impact on asthma scoringTimepoint: 3 months